Advertisement

Kardiovaskuläre Regulationsmechanismen bei der Hypertonie während der Schwangerschaft

  • W. Künzel
Conference paper

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Brown MA, Gallery EDM (1988) Sodium excretion in normal and hypertensive pregnancy: A prospective study. Am J Obstet Gynecol 159: 297PubMedCrossRefGoogle Scholar
  2. Butters L, Kennedy S, Rubin PC (1990) Atenolol in essential hypertension during pregnancy. BMJ 301: 587PubMedCrossRefGoogle Scholar
  3. Capeless EL, Clapp JF (1989) Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol 161: 1449PubMedCrossRefGoogle Scholar
  4. Casper FW, Seufert RJ, Schäfer W, Friedberg V (1992) Tierexperimentelle Untersuchungen zur Präeklampsie. Gynäkologe 25: 364PubMedGoogle Scholar
  5. Clapp JF (1985) Maternal heart rate in pregnancy. Am J Obstet Gynecol 152: 659PubMedCrossRefGoogle Scholar
  6. Clark BA, Halvorson L, Sachs B, Epstein FH (1992) Plasma endothelin levels in preeclampsia: Elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 166: 962PubMedCrossRefGoogle Scholar
  7. Dekker GA, Sibai BM (1993) Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials. Am J Obstet Gynecol 168: 214PubMedCrossRefGoogle Scholar
  8. Everett RB, Worley RJ, MacDonald PC, Gant NF (1978) Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in Human pregnancy. J Clin Endocr Metab 46: 1007PubMedCrossRefGoogle Scholar
  9. Firth JD, Ratcliffe PJ, Raine AEG, Ledingham JGG (1988) Endothelin: an important factor in acute renal failure. Lancet 2: 1179PubMedCrossRefGoogle Scholar
  10. Fitzgerald DJ, Mayo G, Catella F (1987) Increase thromboxane biosynthesis in normal pregnancy is mainly derived from the platelets. Am J Obstet Gynecol 157: 325PubMedCrossRefGoogle Scholar
  11. Girndt J (1987) Hochdrucktherapie während Schwangerschaft und Stillperiode. Münch med Wsch 123: 1819Google Scholar
  12. Harake B, Raymond DG, Ashwal S, Power GG (1987) Nifedipine: Effects on fetal and maternal hemodynamics in pregnant sheep. Am J Obstet Gynecol 157: 1003PubMedCrossRefGoogle Scholar
  13. Harper A, Murnaghan GA (1991) Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. Br J Obstet Gynaecol 98 (5): 453–459PubMedCrossRefGoogle Scholar
  14. Hulton SA, Thomson PD, Cooper PA, Rothberg AD (1990) Angiotensin-Converting enzyme-inhibitors in pregnancy may result in neonatal renal failure. S Afr Med J 78 (11): 673PubMedGoogle Scholar
  15. Keith JC, Thatcher CD, Schaub RG (1987) Beneficial effects of U-63,557 A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension. Am J Obstet 157: 199CrossRefGoogle Scholar
  16. King AJ, Pfeffer JM, Pfeffer MA, Brenner BM (1990) Systemic hemodynamic effects of endothelin in rats. Am J Physiol 258: 787Google Scholar
  17. Koväcs L, Molnär BG, Huhn E, Bödis L (1988) Magnesiumsubstitution in der Schwangerschaft. Eine prospektive, randomisierte Doppelblindstudie. Geburtsh Frauenheilk 48: 595PubMedCrossRefGoogle Scholar
  18. Künzel W (1990) Das „Goldblatt-Phänomen“am Uterus und die latente Nierenerkrankung als Ursache der schwangerschaftsinduzierten Hypertonie — Epidemiologie und therapeutische Konsequenzen. Geburtsh Frauenheilk 50: 833PubMedCrossRefGoogle Scholar
  19. Künzel W, Braems G, Jensen A (1991) Oxygen consumption of the fetus under hypoxic conditions. A hypothesis for the development of pregnancy induced hypertension. In: Cosmi EV, Di Renzo GC (eds) Hypertension in Pregnancy. Monduzzi Editore, BolognaGoogle Scholar
  20. Li J, Hu HY, Zhao YN (1992) Serum angiotensin-converting enzyme activity in pregnancy-induced hypertension. Gynecol Obstet Invest 33: 138PubMedCrossRefGoogle Scholar
  21. Lipschitz J, Ahokas RA, Reynolds SL (1987) The effect of hydralazine on placental perfusion in the spontaneously hypertensive rat. Am J Obstet Gynecol 156: 356CrossRefGoogle Scholar
  22. Losse H, Zidek W, Dorst KG, Vetter H, Zumkley H (1982) Die Bedeutung intrazellulärer Elektrolyte bei der arteriellen Hypertonie. Herz/Kreislauf 14: 27Google Scholar
  23. Losse H (1983) Kochsalz und Hypertonie, Stellen-wert in der Entstehung und für die Langzeittherapie. Inform Arzt Jg 11, 8: 16Google Scholar
  24. Madeddu P, Troffa C, Glorioso N et al. (1989) Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats. J Cardiovasc Pharmacol 14: 818PubMedCrossRefGoogle Scholar
  25. Magness RR, Roy T, Rosenfeld CR (1992) Endothelium-derived relacing factor (EDFR) modulates estradiol-17ß-induced increases in uterine blood flow (UBF) in nonpregnant sheep. (Abstract 567) In: Proceedings of the thirty-ninth annual meeting of the Society for Gynecologic Investigation, San Antonio, Texas, March 18–21Google Scholar
  26. Montan S, Anandakumar Ch, Arulkumaran S, Ingemarsson I, Ratnam ShS (1993) Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 168: 152PubMedCrossRefGoogle Scholar
  27. Moncada S, Radomski MW, Palmer RMJ (1988) Endothelium-derived relaxing factor. Indentification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37: 2495PubMedCrossRefGoogle Scholar
  28. Mondon F, Malassine A, Tobaut Ch et al. (1993) Biochemical characterization and autoradiographic localization of [125] endothelin-1 binding sites on trophoblast and blood vessels of human placenta. J Clin Endocr Metab 76: 237PubMedCrossRefGoogle Scholar
  29. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524PubMedCrossRefGoogle Scholar
  30. Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664PubMedCrossRefGoogle Scholar
  31. Palmer RMJ, Rees DD, Ashton DS, Moncada S (1988) L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Bioche Biophys Res Commun 153: 1251CrossRefGoogle Scholar
  32. Samuels Ph, Steinfeld JD, Braitman LE, Rhoa MF, Cines DB, McCrae KR (1993) Plasma concentration of endothelin-1 in women with cocaine-associated pregnancy complications. Am J Obstet Gynecol 168: 528PubMedCrossRefGoogle Scholar
  33. Sanchez-Ramos L, O’Susslivan J, Garrido-Claderon J (1987) Effect of low-dose aspirin on angiotensin II pressor response in human pregnancy. Am J Obstet Gynecol 156: 193PubMedCrossRefGoogle Scholar
  34. Suonio S, Saarikoski S, Tahvanainen K, Pääkkönen A, Olkkonen H (1985) Acute effects of dihydralazine mesylate, furosemide and metropolol on maternal hemodynamis in pregnancy induced hypertension. Am J Obstet 155: 122CrossRefGoogle Scholar
  35. Schmidt H, Klein MM, Niroomand F, Bohne E (1988) Is arginine a physiological precursor of endothelium-derived nitric oxide? Eur J Pharmacol 148: 293PubMedCrossRefGoogle Scholar
  36. Valenzuela GJ, Longo LD (1985) The relation of maternal blood volume to plasma renin activity in the pregnant rabbit. Journal of Developmental Physiology 7: 99PubMedGoogle Scholar
  37. Van Assche FA, Spitz B, Vermylen J, Deckmyn H (1984) Preliminary observations on treatment of pregnancy-induced hypertension with a thromboxane synthetase inhibitor. Am J Obstet Gynecol 148: 216PubMedCrossRefGoogle Scholar
  38. Van Assche FA, Spitz B, Hanssens M et al (1992) Prostacyclin and thromboxane in pregnancy. Curr Obstet Gynecol 2: 247Google Scholar
  39. Van Assche FA, Spitz B, Hanssens M, Van Geet Ch, Arnout J, Vemylen J (1993) Increased thromboxane formation in diabetic pregnancy as a possible contritubor to preeclampsia. Am J Obstet Gynecol 168: 84PubMedCrossRefGoogle Scholar
  40. Van Buren GA, Yang D, Clark KE (1992) Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167, 3: 828PubMedCrossRefGoogle Scholar
  41. Van Buren GA, Lang U, Yang DS, Clark KE (1992) Nitric oxide synthesis inhibition in pregnant and nonpregnant sheep: maternal and fetal hemodynamic responses (Abstract 566). In: Proceedings of the thirty-ninth annual meeting of the Society for Gynecologic Investigation, San Antonio, Texas, March 18–21Google Scholar
  42. Van Geet C, Arnout J, Eggermont E, Vermylen J (1990) Urinary thromboxane B 2 and 2,3-dinor-thromboxane B2 in the neonate born at full- term age. Eicosanoids 3: 39PubMedGoogle Scholar
  43. Walters BNJ, Redman WG (1984) Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine. Br J Obstet and Gynecol 91: 330CrossRefGoogle Scholar
  44. Wallenburg HCS (1987) Changes in the coagulation system and platelets in pregnancy-induced hypertension and pre-eclampsia. In: Sharp F, Symonds EM (eds) Hypertension in Pregnancy. Perinatology Press, Ithaca, New York, 227Google Scholar
  45. Yang D, Clark KE (1992) Effect of endothelin-1 on the uterine vasculature of the pregnant and estrogen-treated nonpregnant sheep. Am J Obstet Gynecol 167: 1642PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • W. Künzel

There are no affiliations available

Personalised recommendations